- María D. Lozano
- José Echeveste
- Carlos de Andrea
- Marta Abengózar
- Laura Álvarez Gigli
- Allan Argueta
- Laura García Tobar
- José J Paricio
- Guillermo García
- Tania Labiano
Director of Cytopathology.
The Johns Hopkins Hospital. Baltimore, USA
Dr. Ali serves as Professor of Pathology and Radiology at the Johns Hopkins University School of Medicine as well as the Director of the Division of Cytopathology at The Johns Hopkins Hospital. He received his Pathology residency training at North Shore University Hospital in New York with fellowships in Surgical Pathology at the Memorial Sloan-Kettering Cancer Center in New York and Cytopathology at The Johns Hopkins Hospital.
Known globally as an innovative educator, Dr. Ali has well over 350 invited lectures, keynote speeches and visiting professorships all over the world. In collaboration with international societies and universities, he directs or co-directs several annual major cytopathology tutorials.
Dr. Ali has published extensively with over 300 articles in major scientific journals, over 35 books, book chapters and electronic media. Known for his expertise in “Thyroid” and “Pancreatic” cytopathology, his monograph on “The Bethesda System for Reporting Thyroid Cytopathology” has been translated in 7 languages and is extensively used in medical practice all over the world. He is the founding editor-in-chief of the Journal of the American Society of Cytopathology (JASC) and has served as member of the executive board and chair of the scientific program committee and the educational development committee of the American Society of Cytopathology (ASC). He is a past-President of the ASC, and presently serves as the Vice President of the International Academy of Cytology (IAC) and chair of the International Board of Cytopathology of the IAC. He is a fellow of both, the Royal College of Pathologists (UK) and the IAC. He is recipient of the ASC’s “Warren R. Lang Award” in 1996, the “President’s Award” in 2012, “Excellence in Education Award” in 2015 and the IAC’s “Maurice Goldblatt Award” in 2019.
Johns Hopkins Medical Institutions
Dr. Peter Bela Illei is an associate professor of Pathology and Oncology at the Johns Hopkins University School of Medicine and a member of the Division of Cytopathology. His areas of clinical expertise include cytopathology, pulmonary pathology, transplant pathology, and lung cancer biomarkers.
Dr. Illei earned his medical degree from The University of Pécs School of Medicine in Hungary. He completed a pathology residency at New York University Medical Center followed by fellowships in oncologic surgical pathology and cytopathology at Memorial Sloan Kettering Cancer Center. Following his fellowship he was a visiting investigator in the Kettering Institute at Memorial Sloan Kettering Cancer Center. He then joined the Department of Pathology of NYU School of Medicine and subsequently Johns Hopkins University School of Medicine. He also served as the director of the Immunohistochemistry Laboratory at the Johns Hopkins Hospital. Currently, Dr. Illei leads the Thoracic Pathology consult service of the Department.
Dr. Illei’s research interests include development of novel immunohistochemical and molecular markers for the diagnosis of solid tissue tumors, pathology of lung cancer and mesothelioma, as well as lung transplantation.
Dr. Illei served on several institutional committees, and as expert or review panel member of national organizations (CAP, USCAP, ASC, ACCP). He is currently serving as editorial board member of the journals and reviewers of over a dozen pyblications. He was invited speaker and workshop faculty at both national and international pathology/cytopathology conferences, and has authored 136 peer reviewed publication and two book chapters.
Medipath & American Hospital of Paris, France
Dr. Philippe Vielh directed the cytopathology unit at Institut Curie (Paris, France) for 13 years before moving to Gustave Roussy comprehensive cancer center (Villejuif, France) where he headed the cytopathology unit (2003-2015), the histocytopathology unit of the translational research laboratory (2007-2014), and the institutional biobank (2011-2014). He then worked (2015-2019) at the Laboratoire National de Santé (Dudelange, Luxembourg) where he was mainly in charge of cytopathology. He is now working at Medipath and the American Hospital of Paris (France).
Dr Vielh is interested in the study of omics of breast and thyroid tumors. He has authored more than 320 articles in peer-reviewed journals, 7 books and 30 book chapters.
Philippe Vielh is currently the Editor-in-Chief of the journal Cytopathology since January 2021, Associate Editor of the Journal of Molecular Pathology since July 2020 and has been the series’ Editor of the Karger book collection entilted « Monograph in Clinical Cytology » between 2016 and 2020.
He is on the editorial board and reviews for Archives of Pathology and Laboratory Medicine, Diagnostic Cytopathology, Cancer Cytopathology, Acta Cytologica, Journal of the American Society of Cytology, Journal of Pathology and Translational Medicine, Cytopathology, and Cytojournal.
He is member of the American Society of Cytopathology (ASC) and holds a number of national and international society memberships including the fellowship of the International Academy of Cytology (FIAC).
Philippe was honored to serve as President of the French Society of Cytology (SFCC) for 9 years (1996-2006), President of the 31st European Congress of Cytology in 2005 (Paris, France) and Secretary General of the European Federation of Cytology Societies (EFCS) for 7 years (2005-2012). He chaired the 18th International Congress of Cytology in Paris (May 2013), was President of the International Academy of Cytology (IAC) for 3 years (May 2013-June 2016) and then IAC Past-President until May 2019. He is now Chair of the European Society of Pathology (ESP) Cytopathology Working Group since 2018.
Philippe is Professor of Pathology affiliated at the Faculty of Medicine of the University of Porto (Portugal) since December 2017.
He is recipient of the 2007 Papanicolaou Society of Pathology’s L.C. Tao “Educator of the Year” Award, the 2016 International Academy of Cytology’s Maurice Goldblatt Award and the 2019 American Society of Cytopathology’s International Achievement Award.
Head, Molecular Pathology Unit, IPATIMUP. Porto, Portugal
Professor Fernando Schmitt is Professor of Pathology at the University of Porto, Director of RISE (Clinical and Translational Research Network of the Medical Faculty) and Head of Molecular Pathology Unit at IPATIMUP, Past-President of the International Society of Breast Pathology and General Secretary and President-elect of the International Academy of Cytology (IAC).
He has authored more than 500 papers in peer-review journals, 33 book chapters and he is editor of six books, one of molecular pathology, one of molecular cytology, one in serous effusions, other of cytopathology and other two of breast cytopathology.
Prof Schmitt is widely considered a world-leading expert in cytopathology and breast cancer. Fernando was a fellow at the Karolinska Medical Hospital, Stockholm, and was Professor of Pathology at the University of São Paulo (USP), Brazil and University of Toronto, Canada. He was also Director of the Department of Medicine at Laboratoire national de santé, Luxembourg. His research work is on breast cancer, with emphasis on molecular markers, cell adhesion and invasion, therapeutic targets and mechanisms of resistance. In the last years, his research work has been dedicated to the study of molecular markers on cytological material.
Fernando serves as Editor in Chief of Pathobiology and Associate Editor of six major scientific journals and sits on the editorial board of many others. He is standing member of WHO Classification of Tumours – International Academy of Cytology. He has also been chair, president or scientific director of several major European, Portuguese and Brazilian scientific societies of pathology and cytology. Fernando received the following prizes: Educator of the Year 2011 by the Papanicoloau Society of Cytology (USA), GOLDBLATT AWARD 2013 from the International Academy of Cytology, Dario Cruz 2018 from the Portuguese League Against Cancer for his career as researcher in breast cancer and 2021 International Achievement Award from the American Society of Cytopathology.
Director of Pathology & Cytopathology.
Hospital del Mar. Barcelona
Dr.Belen Lloveras is Chairman of the Pathology Department at Hospital del Mar in Barcelona. She is specialist in Cytopathology, Gyneopathology and Endocrine pathology. Her research is focused on HPV related disease and has been actively involved in introducing HPV-based screening for cervical cancer in Spain. She is the past-President of the Spanish Society of Cytology and Professor of Pathology at the Autonomous University of Barcelona.
James Cancer Hospital And Solove Reaearch Institute. Columbus, Ohio. USA
Dr. Paul Wakely, Jr. is a tenured Professor in the Department of Pathology, College of Medicine at The Ohio State Wexner Medical Center, James Cancer Hospital and Solove Research Institute and an Adjunct Professor in the Department of Otolaryngology.
He subspecializes in head and neck, soft tissue/bone surgical pathology and cytopathology. A graduate of St. Louis University School of Medicine, he began his pathology training at the U. of Michigan, Ann Arbor, MI. after completing a residency in clinical pediatrics. Further training consisted of a fellowship in pediatric pathology in Cincinnati, OH, and laboratory medicine training at the Johns Hopkins Hospital, Baltimore, MD. After 11 years at the Medical College of Virginia, and brief tenures in private practice, he has been at the OSU Wexner Medical Center since 1998.
He has over 220 peer-reviewed publications, has authored or co-authored 17 book chapters and monographs, and is the author, co-author, or co-editor of 6 texts in pathology. He previously served as Associate Editor for Journal of American Society of Cytopathology (JASC), and Cancer Cytopathology. He is currently a member of the editorial boards of the journals Seminars in Diagnostic Pathology, JASC, and Annals of Diagnostic Pathology. Dr. Wakely has lectured at multiple venues in the U.S., and abroad.
Director of Pathology & Cytopathology.
Clínica Universidad de Navarra. Pamplona
Associate professor of pathology.
Medical Faculty of University of Navarra. Pamplona
Dr. Lozano graduated and obtained PhD in Medicine and Surgery from the University of Navarra. She specialized in Pathology at the University Clinic of Navarra (CUN). Dr. Lozano completed a postdoctoral stay at the University of Nebraska Medical Center, in the Department of Pathology and Microbiology (March 1993-April 1995). Currently, Dr. Lozano is director of the Department of Pathology of the Clínica Universidad de Navarra, Pamplona, and Head of cytopathology and molecular pathology in cytology. Dr. Lozano is Associate Professor of Pathology at Medical School of the University of Navarra. She is the President of Spanish Society of Cytopathology.
Active member of SEAP (Sociedad Española de Anatomía Patológica), SEC (Sociedad Española de Citología), ESP (European Society of Pathology and Member of the Cytopathology Working group), ASC American Society of Cytopathology , IAC (International Academy of Cytology).
Member of the expert panel for biomarker guidelines of the Spanish Societies of Pathology and Medical Oncology (SEOM).
Member of Editorial boards of Several journals
As researcher, Dr. Lozano is part of multidisciplinary teams within the university itself, as well as national and international levels. She has special dedication to lung and pancreas cytopathology as well as great interest and extensive experience in new approaches of FNAB and the development and application of molecular techniques in cytological samples and small samples by obtaining material using minimally invasive methods. She is deeply involved in the study of tumor microenvironment in lung and pancreatic tumors. She dedicates also to surgical pathology of Lung and Mediastinum.
Dr. Lozano has written more than 190 articles in national and international scientific journals. She has presented more than 400 communications to meetings, more than 200 lectures given, as well as several courses on FNA and molecular biology applied to cytopathology.
DAY ONE: THURSDAY September 9th, 2021
Opening and Introduction (Syed Ali, Maria D. Lozano)
8.45 – 10.15a
1. Thyroid Cytopathology – Bethesda 2010, 2017 and Beyond – S. Ali
2. Thyroid Nodules: Multimodal Diagnostic Approach and Follow-up Findings – S. Ali
10.15 – 10.30a
10.30 – 11.30a
The Milan System for Reporting Salivary Gland Cytopathology – P. Vielh
11.30 – 12.30p
Cytopathology of Non-Salivary/Non-Thyroidal Lesions of Head and Neck – P. Wakely
12.30 – 13.30p
1.30 – 2.30p
Soft Tissue Cytopathology: Coupling Morphology With Ancillary Testing for Diagnostic Accuracy – P. Wakely
2.30 – 2.45p
2.45 – 4.30p
The International System for Reporting Serous Fluid Cytopathology – F. Schmitt
4.30 – 5.15p
The Paris System for Reporting Urinary Cytology – P. Vielh
5.15 – 5.30p
The ICC 2022 – Baltimore (A short Movie)
DAY TWO: FRIDAY September 10th, 2021
8.30 – 9.30a
The International Academy of Cytology Yokohama System for Reporting Breast Fine-Needle Aspiration Biopsy Cytopathology – F. Schmitt
9.30 – 10.30a
Diagnostic Challenges in Pulmonary Cytopathology – MD Lozano
10.30 – 10.45a
10.45 – 11.45p
Lung Cancer Management – Critical Role of Cytopathology –P. Illei
11.45 – 12.30p
Immunostains in Cytopathology. The Good, The Bad and The Unnecessary – P. Illei
12.30 – 1.30p
1.30 – 2.30p
Pancreatic Cytopathology – “Walking On A Tightrope” – S. Ali
2.30 – 3.30p
Role Of HPV And Ancillary Testing In GYN Cytology – B. Lloveras
3.30 – 3.45p
3.45 – 4.30p
Cervical Cytology: Overview and Challenges – S. Ali
4:30 – 5.30p
Challenging Unknowns From Two Sides Of The Atlantic – S.Ali and MD Lozano
Closing Remarks – S.Ali and MD Lozano
Simultaneous translation available.
Registration includes attendance at all work sessions, coffees and lunches on September 9th and 10th, 2021.
Accommodattion & Leisure
Town Hall Square
"La Ciudadela" (Citadel)